p-MEK expression predicts prognosis of patients with adenocarcinoma of esophagogastric junction (AEG) and plays a role in anti-AEG efficacy of Huaier
- 2 January 2021
- journal article
- research article
- Published by Elsevier BV in Pharmacological Research
- Vol. 165, 105411
- https://doi.org/10.1016/j.phrs.2020.105411
Abstract
No abstract availableFunding Information
- National Natural Science Foundation of China
- Natural Science Foundation of Zhejiang Province
This publication has 43 references indexed in Scilit:
- The effects of polysaccharides from Auricularia auricula (Huaier) in adjuvant anti-gastrointestinal cancer therapy: A systematic review and network meta-analysisPharmacological Research, 2018
- Current Management of Locally Advanced Junction Esophagogastric AdenocarcinomaChirurgia, 2018
- Diallyl disulfide inhibits the metastasis of type Ⅱ esophageal‑gastric junction adenocarcinoma cells via NF-κB and PI3K/AKT signaling pathways in vitroOncology Reports, 2017
- Transarterial chemoembolization combined with Huaier granule for the treatment of primary hepatic carcinomaMedicine, 2017
- Results of a nation-wide retrospective study of lymphadenectomy for esophagogastric junction carcinomaGastric Cancer, 2016
- Equol Induces Mitochondria-Dependent Apoptosis in Human Gastric Cancer Cells via the Sustained Activation of ERK1/2 PathwayMolecules and Cells, 2016
- The multidisciplinary management of gastro-oesophageal junction tumoursDigestive and Liver Disease, 2016
- RAP1-mediated MEK/ERK pathway defects in Kabuki syndromeJCI Insight, 2015
- The expression of c-Met pathway components in unclassified pleomorphic sarcoma/malignant fibrous histiocytoma (UPS/MFH): a tissue microarray studyHistopathology, 2011
- Verification and Unmasking of Widely Used Human Esophageal Adenocarcinoma Cell LinesJNCI Journal of the National Cancer Institute, 2010